Cc1cc(S(=O)(=O)Nc2cc(N)n[nH]2)c(SCc2nc(N)nc(N(C)C)n2)cc1Cl
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?